MedTrace Logo

A Study in Patients with a Descending TAA or PAU Treated with the E-nya Thoracic Stent Graft System

NCT04381507 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2024-10-18

No results posted yet for this study

Summary

The CONFORM-TAA post-market clinical follow-up study is undertaken to evaluate the prevention of death related to a descending aortic aneurysm or PAU when treated by the E-nya Thoracic Stent Graft System. The secondary objective is to evaluate the safety and clinical performance of the device.

Conditions

  • Vascular Aneurysm

Interventions

DEVICE

endovascular repair

Endovascular repair of descending thoracic aneurysms or PAU using a stent graft.

Sponsors & Collaborators

  • MedPass International

    collaborator INDUSTRY

  • JOTEC GmbH

    lead INDUSTRY

Principal Investigators

  • Jan Brunkwall, Prof. · Brumed

  • Jost P. Schäfer, Prof. · University Hospital Schleswig-Holstein (UKSH) Kiel

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-12
Primary Completion
2024-07-24
Completion
2024-07-24

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04381507 on ClinicalTrials.gov